Literature DB >> 2194533

Oncogenes and tumor growth factors in breast cancer. A minireview.

I T Ernberg1.   

Abstract

Five oncogenes have been implied as having a role in human breast tumorigenesis: int-2, c-erbB-2 (HER-2), c-myc, c-Ha-ras and the recessive Rb-1. As far as the function and biochemistry of these oncogenes have been studied, they act at different levels and have totally different functions in the cells. They are normally cellular genes, likely to have important functions in normal cell growth or differentiation. In the tumors their regulation or function is altered, due to a wide class of mutations. The oncogenes may cooperate to result in the malignant cell phenotype. However, different oncogenes are mutated in different tumors, so that the tumors show a variable pattern at the molecular level, underlining the individuality of these tumors already described as differences in histopathology, hormone receptor expression and clinical course. The main importance of the oncogene studies is still to reveal basic pathogenetic mechanisms. When appropriate it is important to test diagnostic or prognostic significance of the oncogene mutations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194533     DOI: 10.3109/02841869009090009

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress.

Authors:  Jennifer S Tront; Yajue Huang; Albert J Fornace; Albert A Fornace; Barbara Hoffman; Dan A Liebermann
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

2.  Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures.

Authors:  Jean J Latimer; Tariq Nazir; Lisa C Flowers; Michael J Forlenza; Kelly Beaudry-Rodgers; Crystal M Kelly; Julie A Conte; Kenneth Shestak; Amal Kanbour-Shakir; Stephen G Grant
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

3.  Expression of somatostatin type 2A receptor correlates with estrogen receptor in human breast carcinoma.

Authors:  M Pilichowska; N Kimura; M Schindler; A Suzuki; R Yoshida; H Nagura
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

4.  Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.

Authors:  K I Bland; M M Konstadoulakis; M P Vezeridis; H J Wanebo
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

Review 5.  Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other?

Authors:  Irati Beltrán Hernández; Jannes Z Kromhout; Erik Teske; Wim E Hennink; Sebastiaan A van Nimwegen; Sabrina Oliveira
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

6.  Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.

Authors:  S G Archer; A Eliopoulos; D Spandidos; D Barnes; I O Ellis; R W Blamey; R I Nicholson; J F Robertson
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.